The Hematology/Oncology Division is devoted to state-of-the-art and compassionate treatment in malignant and non-malignant blood disorders, hemostasis and thrombosis, hematopoietic stem cell transplantation and cellular therapeutics, and solid tumor oncology. We are committed to improving care for tomorrow’s patients and have robust clinical trials and translational research programs. Our 35 hematologists/oncologists provide care at our outpatient facilities at the Emily Couric Clinical Cancer Center or in our Community Oncology sites in Fishersville, Culpeper, and Charlottesville (Pantops location). We provide comprehensive care in our inpatient Hematology/Oncology and stem cell units and on the hematology and oncology consultation services.
UVA Comprehensive Cancer Center Director Thomas P. Loughran Jr., MD, and Professors of Medicine/ Hematology and Oncology Charles Chalfant, PhD, and David Feith, PhD, have been awarded a new five-year, $13 million National Cancer Institute (NCI) program project grant to lead a multiinstitution, interdisciplinary study seeking new therapies for acute myeloid leukemia (AML).
Comprehensive Cancer Center tapped as ‘Great Oncology Program’
Becker’s Hospital Review included UVA Health and UVA Comprehensive Cancer Center on its 2025 list of 100 hospitals and health systems with great oncology programs. “These leading institutions have earned national distinction for advancing cancer care through groundbreaking research, innovative treatments, and transformative clinical trials,” the national health care publication’s editors wrote.
Dr. Craig Portell Discusses Blood Cancer Awareness Month with NBC29 Community Conversation
Several types of blood cancers can present in many ways. Some blood cancers can be associated with environmental exposures; however, those exposures are rare. Symptoms vary between different kinds of blood cancers. There are treatments available, and several blood cancers are even curable.
UVA symposium brings experts together to target hard-to-treat cancers
She was only 66 and in excellent shape, but we did not have access to a transplant in India," recalls Indumathy Varadarajan, MD, of her personal loss that continues to shape her work today at UVA Health. The hematologist-oncologist's maternal grandmother died from acute leukemia, a cancer of the blood-forming tissues.
Meet UVA Medical Oncologist, Dr. Ryan Gentzler
Dr. Gentzler’s clinical focus is the treatment of patients with lung cancer and other thoracic malignancies. His research is centered around the development of novel therapies for lung cancer. His goal is to contribute meaningful research that leads to improvements in the curability, survival, and quality of life for patients with lung cancer.
Meet UVA Hematologist/Oncologist, Karen Ballen, MD
Dr. Ballen is Division Chief of Hematology and Oncology, Section Head, Hematology and Stem Cell Transplantation, and Medical Director - Stem Cell Transplantation Program. Here research interests are in novel treatments for acute leukemia, stem cell transplantation, cord blood transplantation, haploidentical transplantation, immunotherapy treatment for hematologic malignancies.
Meet Hematologist Louise Man, MD
Dr. Man manages patients with a spectrum of benign hematological conditions. She has a clinical interest in quality improvement and a research interest in disorders of thrombosis and hemostasis.
